Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. | Environ Res | 2022 | 35093310 | PubTator, text mining | PubMed |
| Human genetic and immunological determinants of critical COVID-19 pneumonia. | Nature | 2022 | 35090163 | PubTator, text mining | PubMed |
| The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic? | J Epidemiol Glob Health | 2022 | 35089588 | PubTator, text mining | PubMed |
| Structural biology of SARS-CoV-2: open the door for novel therapies. | Signal Transduct Target Ther | 2022 | 35087058 | PubTator, text mining | PubMed |
| Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease. | ChemMedChem | 2022 | 35085423 | PubTator, text mining | PubMed |
| Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen. | J Virol | 2022 | 35080424 | PubTator, text mining | PubMed |
| Trypsin enhances SARS-CoV-2 infection by facilitating viral entry. | Arch Virol | 2022 | 35079901 | PubTator, text mining | PubMed |
| The chemical constituents of Sterculia comosa (wall) Roxb woods for arginase inhibitory, antioxidant activity, and molecular docking against SARS CoV-2 protein. | Heliyon | 2022 | 35079656 | PubTator, text mining | PubMed |
| Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target. | Virusdisease | 2022 | 35079600 | PubTator, text mining | PubMed |
| Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery. | J Infect Public Health | 2022 | 35078755 | PubTator, text mining | PubMed |
| The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2. | FEMS Microbiol Rev | 2022 | 35076068 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. | Signal Transduct Target Ther | 2022 | 35075101 | PubTator, text mining | PubMed |
| Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host. | Int Immunopharmacol | 2022 | 35074569 | PubTator, text mining | PubMed |
| Oral antivirals for the prevention and treatment of SARS-CoV-2 infection. | AIDS Rev | 2022 | 35073629 | PubTator, text mining | PubMed |
| RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2. | Gene Rep | 2022 | 35071824 | PubTator, text mining | PubMed |
| Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19. | Acta Pharmacol Sin | 2022 | 35058587 | PubTator, text mining | PubMed |
| Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine. | Life (Basel) | 2022 | 35054450 | PubTator, text mining | PubMed |
| A Defective Viral Particle Approach to COVID-19. | Cells | 2022 | 35053418 | PubTator, text mining | PubMed |
| Gut microbiome and diet in populations with obesity: Role of the Na+/K+-ATPase transporter signaling in severe COVID-19. | Obesity (Silver Spring) | 2022 | 35048549 | PubTator, text mining | PubMed |
| JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis. | mBio | 2022 | 35038906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=61